Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for COVID-19 treatment
IRCT20220404054411N1Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluoxetine in coronavirus disease 2019 (COVID-19), sponsored by Semnan University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
fluoxetine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20220404054411N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220404054411N1.